Compare Oscar Health Inc (OSCR) vs SkyWest Inc (SKYW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs SkyWest Inc — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while SkyWest Inc trades at $96.52 (market cap $3.75B). The key difference: Oscar Health Inc is far larger — about 2.7× SkyWest Inc's market cap, and Oscar Health Inc is trading nearer its 52-week high, SkyWest Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and SkyWest Inc for 8 Days on average.
| OSCR | SKYW | |
|---|---|---|
Market Cap | $10.22B | $3.75B |
Volume | 4,123,394 | 196,324 |
Sector | Health | Industrials |
52-Week High | $33.81 | $115.94 |
52-Week Low | $10.85 | $78.40 |
Typical Hold Time | 15 Days | 8 Days |
Enterprise Value | $6.57B | $5.54B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.
Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.
SkyWest (SKYW) trades at $96.52, down 0.12% with a bearish technical signal despite strong analyst support. The stock shows mixed earnings performance with Q1 2026 beating expectations but Q4 2025 and Q2 2026 missing estimates. Fundamentally, the company maintains solid profitability with 9.78% net margin and attractive valuation metrics including a P/E of 9.6. Recent news highlights fleet modernization efforts and expanding flying agreements while executives have been selling shares.
The outlook remains cautiously optimistic with a $112 consensus price target representing 16% upside potential. Key opportunities include fleet expansion and strong cash flow generation, while risks involve cost pressures and recent insider selling activity. The stock presents a value opportunity given its below-market valuation multiples and positive analyst coverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About SkyWest Inc
SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.
Read more on SKYW →
